Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridazine compounds >  ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE

ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE

Basic information Safety Supplier Related

ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE Basic information

Product Name:
ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE
Synonyms:
  • 3,6-Dichloropyridazine-4-carboxylic acid ethyl ester
  • ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE
  • 4-Pyridazinecarboxylic acid, 3,6-dichloro-, ethyl ester
  • ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE ISO 9001:2015 REACH
  • 3,6-Dichloro-5-ethylpyridazine-4-carbaldehyde
CAS:
34127-22-5
MF:
C7H6Cl2N2O2
MW:
221.04
Mol File:
34127-22-5.mol
More
Less

ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE Chemical Properties

Boiling point:
364.2±37.0 °C(Predicted)
Density 
1.433±0.06 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
pka
-3.52±0.10(Predicted)
Appearance
Light yellow to brown Solid-Liquid Mixture
More
Less

ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATE Usage And Synthesis

Synthesis

64-17-5

51149-08-7

34127-22-5

To a suspension of 3,6-dichloropyridazine-4-carboxylic acid (15.0 g, 78 mmol) in tetrahydrofuran (THF, 150 mL) was sequentially added ethanol (18.15 mL, 311 mmol) and 4-dimethylaminopyridine (DMAP, 0.950 g, 7.77 mmol). 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, 16.39 g, 85 mmol) was added in batches over 1 min, and mild exothermic phenomena were observed during the reaction. The reaction mixture was stirred at room temperature for 16 hours. Upon completion of the reaction, the mixture was transferred to a dispensing funnel and neutralized by adding saturated aqueous sodium bicarbonate (NaHCO3) solution (150 mL). The aqueous phase was extracted with ether (3×250 mL), and the combined organic phases were washed with saturated saline (100 mL), dried over anhydrous magnesium sulfate (MgSO4), filtered and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (eluent: 20%→40% ethyl acetate/hexane solution; amount of silica gel: 300 g) to afford ethyl 3,6-dichloro-4-pyridazine-carboxylate (13.2 g, 59.7 mmol, 77% yield) as a colorless oil. The product was characterized as follows: 1H NMR (400 MHz, CDCl3) δ 7.88 (s, 1H), 4.50 (q, J = 7.0 Hz, 2H), 1.46 (t, J = 7.2 Hz, 3H); LCMS (ESI) m/e 221.1 [(M + H)+, theoretical value 221.0 (C7H7Cl2N2O2)].

References

[1] Patent: WO2018/98411, 2018, A1. Location in patent: Page/Page column 20; 21; 23; 24; 68; 69
[2] Patent: WO2008/130951, 2008, A1. Location in patent: Page/Page column 81
[3] Journal of Medicinal Chemistry, 1993, vol. 36, # 18, p. 2676 - 2688
[4] Patent: WO2008/130600, 2008, A2. Location in patent: Page/Page column 70
[5] Patent: WO2004/108707, 2004, A1. Location in patent: Page 53-54

ETHYL 3,6-DICHLOROPYRIDAZINE-4-CARBOXYLATESupplier

Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
Jiangsu Mingchem Corporation
Tel
0519-85170101
Email
sales@mingchem.com
Struchem Co., Ltd.
Tel
0512-63009836 18994340901
Email
helen@struchem.com
Changzhou Hopschain Chemical Co.,Ltd.
Tel
0519-85528066 13775048983
Email
sales@hopschem.com
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Email
psaitong@jm-bio.com